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Objective. To determine colonization rates of Staphylococcus aureus given the potential for future intervention trials aimed at
reducing surgical-site infectious morbidity, and to estimate methicillin-resistant Staphylococcus aureus (MRSA) rates in our pa-
tient population. Study design. Prospective pilot investigation comprising data from 104 gravidas admitted to an urban labor and
delivery unit. All underwent anterior nares culture collection with a subset also undergoing vaginal culture collection. Results.
Twenty-two percent of women were colonized in the anterior nares. Of the 28 women who had vaginal cultures collected, 4/28
(14.2%) demonstrated Staphylococcus aureus colonization. There was 82% concordance between the nares and vagina. Nine per-
cent of isolates were MRSA strains. Overall, 2/96 (2.1%) of women were MRSA-colonized. Conclusions. Rates of Staphylococcus
aureus colonization among gravidas entering labor and delivery are modest and consistent with the general population. MRSA
rates among gravidas appear to be reassuringly low in this pilot study.
Copyright © 2007 R. Beigi and J. Hanrahan. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
Staphylococcus aureus is a common bacterial pathogen fre-
quently found to colonize skin, anterior nares, or perineum
in humans. Nasal carriage rates are 25–50% in the gen-
eral population [1, 2]. S. aureus is a major cause of skin
and surgical-site infections, and is one of the most com-
mon causes of healthcare-associated infections. Methicillin-
resistant S. aureus (MRSA) has been a growing problem in
healthcare facilities since the 1960s, and has become gradu-
ally more diﬃcult to treat due to increasing resistance [3].
MRSA was once considered to be a problem primarily
related to transmission in healthcare facilities due to cross-
transmission on the hands of healthcare workers [4]. How-
ever, in the last ten years, there have been multiple outbreaks
MRSA in people with no direct contact with healthcare set-
tings, and no apparent risk factors for acquiring MRSA [5].
Community-acquired MRSA (CA-MRSA) infections have
been increasingly reported, including invasive infections in
children, outbreaks in correctional settings, athletic teams,
and among men who have sex with men [5]. CA-MRSA in-
fectionhasbeenrecognizedworldwide,anditsincreaseposes
serious implications for hospitals in that the pool of indi-
viduals colonized with MRSA will likely increase with subse-
quent increased potential for spread in hospitals.
The carriage rate for S. aureus and MRSA among women
presenting for obstetric care has not been recently evaluated.
An evaluation published in 1978 of S. aureus nasal coloniza-
tion among asymptomatic gravidas admitted to labor and
delivery documented a 4% colonization rate [6]. The impor-
tance of S. aureus colonization as a marker for subsequent
surgical-site infectious morbidity is well documented [7, 8].
S.aureusisthoughttobeacausativeagentinroughly25-50%
of cesarean section infectious wound morbidity and puer-
peral mastitis [9]. With the ever-increasing rates of cesarean
delivery, recognition of potentially modiﬁable risk factors for
surgical-site infectious morbidity becomes imperative.
MRSA is a cause of invasive disease in infants in neonatal
intensive care units. The existence of MRSA colonization in
pregnant women has potential serious implications for new-
borns [10–12], and may cause an increased rate of infection
in both pregnant women and infants. Despite the potential
implications, a paucity of data currently exists addressing
MRSAratesamonggravidas.Inlightoftheseconcernsapilot2 Infectious Diseases in Obstetrics and Gynecology
investigation into the prevalence of S. aureus and MRSA col-
onization in women presenting to the labor and delivery for




This was a prospectively enrolled cohort analysis of 104
gravidas admitted to labor and delivery for labor manage-
ment or scheduled cesarean section from April 2005 thru
March 2006 at MetroHealth Medical Center (Cleveland,
Ohio, USA). MetroHealth Medical Center is the Cuyahoga
Countypublichospital,servingpredominantlytheinner-city
metropolitan Cleveland area. The protocol was approved by
the MetroHealth Medical Center institutional review board
and all patients underwent informed consent.
Women who met the following inclusion criteria were
approached for enrollment by a trained member of the re-
searchstaﬀ:gestationalageatorbeyond24weeks,werebeing
admitted for labor management or scheduled cesarean sec-
tion, and had intact amniotic membranes. Women were ex-
cluded if they had used antibiotics in the week preceding en-
rollment or had already received a pelvic exam that day with
the use of bacteriostatic lubricant gel. At enrollment, demo-
graphic data including age, race, gestational age, and occu-
pation including contact with health-care facilities or health-
care personnel was obtained. All women had anterior nares
swabs collected for S. aureus culture, and a subset also had
swabs collected from the outer third of the vagina for S. au-
reus culture. Women received their regular care as per obstet-
ricindicationandnofurtherfollow-uptookplaceduringthe
incident hospitalization.
At 3 months postpartum the comprehensive clinical care
computer database was searched for any visits the enrolled
women received in the MetroHealth system after delivery
pertaining to infectious morbidity. In addition, all women
were contacted by phone by the trained research assistant to
inquire into infectious conditions they experienced since de-
livery that may have been attributable to S. aureus. Specif-
ically, women were asked if they had been diagnosed by a
health professional with either a surgical wound infection
(for cesarean delivery patients) or mastitis. Women who re-
ported puerperal infectious morbidity to the research per-
sonnel on the phone or who were noted to have had a visit
in the computerized medical record addressing one of these
infections were compared to women without, stratiﬁed by S.
aureus colonization status.
2.2. Microbiology
Swabs from both the anterior nares and vagina were culti-
vated for Staphylococcus aureus in the following manner at
the MetroHealth Medical Center microbiology laboratory:
swabs were plated on TSA II 5% Sheep’s Blood agar (man-
ufacturer: BBL). Plates were then incubated at 37
◦Ci n5 %
CO2 andexamineddailyforgrowth.Coloniesshowingatyp-
ical Staphylococcus morphology were tested for bound co-
agulase using a slide agglutination test with rabbit plasma
“clumping factor.” Colonies demonstrating positive aggluti-
nation in plasma were retested with a saline-negative control
to conﬁrm absence of autoagglutination . Equivocal “clump-
ing factor” tests were resolved with a Tube Coagulase Test
read at 24 hours of incubation. The plates were held 72
hours before cultures were resulted as negative. S. aureus
isolates, then, underwent antimicrobial susceptibility test-
ing via broth microdilution using a Vitek I. MRSA strains
were identiﬁed as those demonstrating an MIC value of ≥
4mg/dL to oxacillin (Clinical and Laboratory Standards In-
stitute (CLSI), Performance standards for antimicrobial sus-
ceptibility testing (Wayne, Pa, USA) ; 2005).
Collation and analysis of the data was performed us-
ing StatView (version 5.0.1, SAS Institute Inc., (Cary, NC,
USA)). Summary statistics were used for description of the
data where appropriate. Fishers’ exact testing for diﬀerences
in proportions was used where appropriate.
3. RESULTS
Of the 104 women enrolled, culture data is available on 96
(92.3%).
This represents approximately 3.5% of the women deliv-
ering at the institution over the time period of the study. The
demographicdataisdisplayedinTable 1.Mostofthewomen
presentedatornearterm,andalargepercentagewereadmit-
ted for scheduled repeat cesarean section delivery.
Of the 96 women with culture data, 21 (22.0%) were col-
onized with S. aureus. All but one (95.4%) of the culture-
positive women carried S. aureus in the anterior nares. One
womanharboredS.aureusinthevaginawithanegativenares
culture. There were seven of the nares-positive women that
also had vaginal cultures taken, and 3 of 7 (42.8%) were cor-
respondingly positive as well. Of the 75 women that were
culture-negativeinthenares,21ofthemalsohadvaginalcul-
tures available, and all but one were culture-negative. Over-
all, of the 28 women with both nares and vaginal cultures
available, 23 (82.1%) were concordant.
Two of the 21 (9.5%) women positive for S. aureus car-
ried MRSA strains (2.1% overall). One of these women
with both nares and vaginal cultures collected demonstrated
MRSA colonization at both sites. Of the two MRSA (+)
women, 1 worked in the study hospital and one denied any
direct hospital/personnel contact other than outpatient pre-
natal care during the entire pregnancy prior to admission to
labor and delivery.
In terms of infectious outcomes, 6 of the 96 women
(6.3%) were noted to have infectious conditions potentially
attributed to S. aureus (4 surgical wound infections and 2
cases of puerperal mastitis). Two of the 21 S. aureus (9.5%)
colonized women had puerperal infectious morbidity versus
4 of 75 (5.3%), however, this did not reach statistical signiﬁ-
cance (P = .61).
4. DISCUSSION
This pilot investigation is the ﬁrst study identiﬁed in nearly
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Health-care exposure during pregnancy? N % Culture (+)
Yes 16 (17%) 25.0
No 80 (83%) 21.2
Delivery mode N % Culture (+)
Vaginal 33 (34%) 18.1
Cesarean 63 (66%) 23.8
otherwise uncomplicated gravidas entering labor and deliv-
ery. We documented a modest overall S. aureus colonization
rate of 22%, of which nearly 10% were MRSA strains. The
S. aureus nares colonization rate in this report approaches
other published reports of the general population of 25–50%
[1, 2]. These ﬁndings could serve as a foundation for fu-
ture intervention trials using topical antimicrobials to de-
crease surgical-site infectious morbidity in patients increas-
ingly undergoing scheduled cesarean delivery. Our overall
MRSA colonization rate of 2.1% approximates the 0.8% rate
noted from 2001-2002 national data [5]. This was a small pi-
lot study and is informative although it may not be general-
izable to the entire pregnant population.
The overall S. aureus nares colonization rate of 22.0%
noted in this study is higher than the only other investigation
addressing nasal colonization among asymptomatic gravi-
das, noting a 4.0% S. aureus nasal colonization in 1978 [6].
Chen et al. recently published S. aureus colonization rates
from rectovaginal specimens collected for routine group B
streptococcus (GBS) cultures done between 35–37 weeks of
gestation and found that 17.1% of nearly 3000 women also
hadevidenceforgenitalS.aureuscolonization[13].Thesub-
set of our women who had vaginal cultures performed (N =
28) showed a comparable rate of 4/28 (14.2%) genital tract
S. aureus colonization. The main goal of this investigation
was to delineate nasal S. aureus and MRSA colonization rates
as a foundation for potential intervention trials using in-
tranasal antimicrobials given the ever-increasing rates of ce-
sarean delivery with its attendant surgical site morbidity. To
this end, the vaginal colonization data was secondary, and is
mentioned as a corollary to nasal colonization in a subset of
women to address concordance in colonization sites.
Too few infectious outcomes with no direct incident cul-
turedataweredetectedinthispilotinvestigationtomakeany
meaningfulstatements,however,itisworthnotingthenearly
2 fold risk seen among women who were S. aureus culture-
positive. Other patient populations have demonstrated an
increase in surgical-site and soft-tissue infectious morbidity
among those colonized with S. aureus [7, 8], but this has not
been demonstrated to date in women undergoing cesarean
section and/or lactating.
A related concern is the emergence and persistence of
CA-MRSAstrainsinthegeneralpopulation. Firstrecognized
in the 1960s, MRSA has become an important pathogen not
only due to its antibiotic susceptibility pattern making eﬃ-
cacious treatment challenging but also because of the sever-
ity of MRSA skin, soft-tissue, and blood-borne infections.
Recent data suggests that CA-MRSA strains persist, placing
women entering labor and delivery at risk for colonization,
infection, and nosocomial transmission and/or acquisition
of MRSA [5]. The rate of 2.1% in this pilot investigation ap-
proximates other reports and is reassuringly low, yet present
nonetheless [5, 13].
Afewlimitationstothecurrentpilotstudyareworthnot-
ing. This is a small study in a single locale, and thus may not
be completely generalizable to the entire obstetric popula-
tion. In addition, our method of assessing postpartum infec-
tious morbidity was limited to patient report and/or search
of an electronic medical record for visits. Thus, our estimates
may not be entirely representative of reality. However, this
wasnotdonewithknowledgeofcolonizationcategorybythe
research personnel conducting the medical record search or
the phone call, and is thus unlikely to be biased with regard
to colonization status. Further, we did not investigate in this
pilot study into the molecular characterization of our strains
and therefore the epidemiology can only be suggested. How-
ever, of our 2 MRSA strain-positive women, 1 denied direct
hospital contact except for outpatient prenatal care, making
CA-MRSA a possibility.4 Infectious Diseases in Obstetrics and Gynecology
In summary, this pilot study demonstrates modest and
population-consistent rates of S. aureus and MRSA colo-
nization rates among uncomplicated gravidas entering labor
and delivery for management of labor. Given the increasing
rates of cesarean delivery documented nationally, this popu-
lation could potentially beneﬁt from interventions aimed at
reducing surgical-site infectious morbidity attributable to S.
aureus. Continued surveillance for CA-MRSA is warranted
among this and other “low-risk” populations due to increas-
ing reports of prevalent strains in the community.
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